Hui Zou

Dr. Hui Zou

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TCTing Chen
Ting Chen
CFChunna Fan
Chunna Fan
YHYonglan Huang
Yonglan Huang
JFJizhen Feng
Jizhen Feng
YZYinhong Zhang
Yinhong Zhang
LHLianshu Han
Lianshu Han
Newborn screening (NBS) to identify severe but treatable disorders in newborns has been extremely successful worldwide in the past few decases.1 Newborn screening using dried blood spot (DBS) specimens was initially designed to detect a single disorder (phenylketonuria) in the 1960s.2 Technological advances, such as the use of tandem mass spectrometry, have played a significant role in the expansion of NBS to a number of disorders simultaneously.3 These DBS-based biochemical NBS methods rely on the measurement of metabolic substances, which resulted in an inherent limitation of screening disorders with specific indicators. Furthermore, biochemical NBS was criticized by its high false-positive rate and the need for differentiate diagnosis.4

Verified
Journal Article
Open access
PDF file
CTChengfang Tang
Chengfang Tang
LLLixin Li
Lixin Li
TCTing Chen
Ting Chen
LYLi Yulin
Li Yulin
BZBo Zhu
Bo Zhu
YHYonglan Huang
Yonglan Huang
The aim of this study was to observe the outcomes of newborn screening (NBS) in a certain population by using next-generation sequencing (NGS) as a first-tier screening test combined with tandem mass spectrometry (MS/MS). We performed a multicenter study of 29,601 newborns from eight screening centers with NBS via NGS combined with MS/MS. A custom-designed panel targeting the coding region of the 142 genes of 128 inborn errors of metabolism (IEMs) was applied as a first-tier screening test, and expanded NBS using MS/MS was executed simultaneously. In total, 52 genes associated with the 38 IEMs screened by MS/MS were analyzed. The NBS performance of these two methods was analyzed and compared respectively. A total of 23 IEMs were diagnosed via NGS combined with MS/MS. The incidence of IEMs was approximately 1 in 1287. Within separate statistical analyses, the positive predictive value (PPV) for MS/MS was 5.29%, and the sensitivity was 91.3%. However, for genetic screening alone, the PPV for NGS was 70.83%, with 73.91% sensitivity. The three most common IEMs were methylmalonic academia (MMA), primary carnitine deficiency (PCD) and phenylketonuria (PKU). The five genes with the most common carrier frequencies were PAH (1:42), PRODH (1:51), MMACHC (1:52), SLC25A13 (1:55) and SLC22A5 (1:63). Our study showed that NBS combined with NGS and MS/MS improves the performance of screening methods, optimizes the process, and provides accurate diagnoses.

28 March 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
RLRuotong Li
Ruotong Li
LTLiping Tian
Liping Tian
QGQing Gao
Qing Gao
YGYuanfang Guo
Yuanfang Guo
GLGaijie Li
Gaijie Li
HZHui Zou
Hui Zou
Objective: Lysosomal storage disorders (LSDs) are becoming increasingly important in newborn screening, and tandem mass spectrometry (MS/MS) is widely used in newborn screening for LSDs through measurement of enzymatic activities in dried blood spots (DBSs). Overall, the determination of the cutoff value is important in such screening, and different laboratories have different methods of determining this value; most do not use a fixed cutoff value but rather calculate the corresponding batch cutoff value based on each batch of experimental data. In this study, we used MS/MS to screen for LSDs and sought to find an appropriate method to establish the cutoff value for LSD screening.Methods: A total of 38,945 samples from newborn blood tablets collected from various maternity hospitals in six cities in Shandong province, including Jinan, Dezhou, Heze, Linyi, Weifang, and Zibo, were tested using a Waters Xevo TQD tandem mass spectrometer; the experimental data were analyzed with MassLynx V4.1. The laboratory used 30% of the median GLA enzyme activity and 20% of the median ABG, ASM, GALC, IDUA, and GAA enzyme activities in every test as the cutoff values for that batch of experiments.Results: There were 254 suspicious positives in the initial screening test, including one case of Gaucher disease, one of Niemann-Pick disease, 47 of Krabbe disease, four of MPS-I, 21 of Fabry disease, and 180 of Pompe disease. After genetic screening, 11 children were diagnosed, including three with Pompe disease, three with Fabry disease, and five with Krabbe disease. In addition, the enzyme activity cutoff value of this experiment showed seasonal variation, which was initially believed to be related to the ambient temperature, such as the effect of ambient temperature on the human body or the temperature when the blood tablets dried naturally.Conclusion: Overall, MS/MS can be used in LSD screening, and using different cutoff values in each batch of experiments is feasible. The ambient temperature might be a reason why the enzyme activity cutoff value has seasonal variation. More samples are needed to develop a method of determining cutoff values in laboratories.

9 March 2022 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Closed access
GLGaijie Li
Gaijie Li
LTLiping Tian
Liping Tian
YGYuanfang Guo
Yuanfang Guo
YLYulin Li
Yulin Li
MSMeng Sun
Meng Sun
HZHui Zou
Hui Zou
To establish cut-off values of lysosomal storage disease (LSD)-related enzymes by tandem mass spectrometry. A total of 26 689 newborns and 7 clinically confirmed LSD children underwent screening for LSDs (glycogen storage disease typeⅡ, Fabry disease, mucopolysaccharidosis type Ⅰ, Krabbe disease, Niemann-Pick disease A/B and Gaucher disease). The activities of LSD-related enzymes were detected by tandem mass spectrometry. The 20% of the median enzyme activity of each batch of acid β-glucocerebrosidase, acid sphingomyelinase, β-galactocerebroside, α- L-iduronidase and acid α-glucosidase, and the 30% of the median enzyme activity of α-galactosidase were taken as cut-off values of corresponding enzymes. The genetic diagnosis was performed in neonates whose enzyme activity was lower than 70% of the cut-off value. The enzyme activities of 7 clinically confirmed cases were all lower than the cut-off values. Among 26 689 newborns, 142 cases (0.53%) were suspected positive for LSDs, including 25 cases of β-galactocerebroside deficiency, 1 case of α- L-iduronidase deficiency, 19 cases of α-galactosidase deficiency, and 97 cases of acid α-glucosidase deficiency. Eight infants were genetically diagnosed with LSDs, including 3 cases of glycogen storage disease type Ⅱ, 3 cases of Krabbe disease, and 2 cases of Fabry disease, with a positive predictive value of about 5.6%. Cut-off values ​​of the 6 LSD enzyme activities all showed a downward trend from March to August, and an upward trend from September to December. There was a statistically significant difference in LSD enzyme activity among different months ( P<0.05). The established cut-off values of LSD-related enzyme activities detected by tandem mass spectrometry can be used for screening LSDs in neonates, and the enzyme activity would be affected by temperature and humidity.

14 November 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SSShan Shan
Shan Shan
MLMin Liu
Min Liu
YMYue Ma
Yue Ma
MSMeng Sun
Meng Sun
YWYue Wang
Yue Wang
HZHui Zou
Hui Zou
Methylmalonic acidemia (MMA) is a rare genetic disorder caused by disruptions in the metabolism of methylmalonic acid, resulting in severe neurological and systemic complications. Animal models have become indispensable in advancing our understanding of MMA pathogenesis, evaluating treatment options, and exploring new therapies. This review highlights recent advancements in MMA research, focusing on the characteristics, advantages, and limitations of various genetically engineered animal models, including murine and zebrafish models. By integrating insights from these models, this work aims to provide a foundation for future clinical applications and therapeutic innovations. Clinical trial number Not applicable.

1 December 2023 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Open access
SMSun Meng
Sun Meng
YLYulin Li
Yulin Li
PLPanpan Li
Panpan Li
GLGaijie Li
Gaijie Li
YYYan Yan
Yan Yan
HZHui Zou
Hui Zou
Objective To retrospectively analyze the variation characteristics of phenylalanine hydroxylase (PAH) gene, and to observe the long-term treatment effect and follow-up of newborns with PAH deficiency. Methods The clinical data, treatment and follow-up results of 198 children with PAH deficiency, which diagnosed by newborn screening in Jinan from 1996 to 2021 were collected. The genetic analysis results of 55 children with PAH deficiency diagnosed by newborn screening in Jinan and 213 children referred from the surrounding areas of Jinan were summarized. Gene mutations were checked by a customized Panel gene detection method. As also as blood phenylalanine-concentration, physical development indicators include height and weight were regularly monitored. Intellectual development was assessed using the neuropsychological development scale for children aged 0-6 years and academic performance, and brain injury in children was assessed using brain magnetic resonance imaging. Results c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G mutations were common in PAH gene. The genotype of c.158G>A mutation is compound heterozygous mutation, mainly mild hyperphenylalaninemia, but it is also found in both classic phenylketo-nuriaand mild phenylketonuria. 168 children with PAH deficiency who were followed up regularly had normal physical development without dwarfism or malnutrition.Among the 33 preschool children who underwent mental development assessment, 2 were mentally retarded and the initial treatment age was older than 6 months. Nine children with an average age of (17.13±2.42) years completed brain magnetic resonance imaging, 1 case was normal and 8 cases were abnormal. Brain magnetic resonance imaging results showed different differences. There were patchy or patchy hyperintense foci near the bilateral lateral ventricles on T2WI, and the intellectual development was normal. The blood phenylalanine concentration of one normal child was better and stably controlled within the ideal range than that of the other eight children. Conclusion c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G mutations were common in PAH gene. After standardized treatment, most children with PAH deficiency diagnosed by screening can obtain normal growth and intellectual development in adolescence, but there are different degrees of organic lesions in the cerebral white matter.